.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Baxter
Chinese Patent Office
Cantor Fitzgerald
Merck
McKesson
Moodys
Johnson and Johnson
Dow
UBS

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065006

« Back to Dashboard
NDA 065006 describes TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, which is a drug marketed by Akorn Inc, Sandoz Inc, and Bausch And Lomb, and is included in three NDAs. It is available from thirteen suppliers. Additional details are available on the TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE profile page.

The generic ingredient in TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE is polymyxin b sulfate; trimethoprim sulfate. There are twelve drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate; trimethoprim sulfate profile page.

Summary for NDA: 065006

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 065006

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
polymyxin b sulfate; trimethoprim sulfate
SOLUTION/DROPS;OPHTHALMIC 065006 ANDA Akorn, Inc. 17478-703 17478-703-11 1 BOTTLE, DROPPER in 1 CARTON (17478-703-11) > 10 mL in 1 BOTTLE, DROPPER
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
polymyxin b sulfate; trimethoprim sulfate
SOLUTION/DROPS;OPHTHALMIC 065006 ANDA Lake Erie Medical DBA Quality Care Products LLC 55700-414 55700-414-10 1 BOTTLE, DROPPER in 1 CARTON (55700-414-10) > 10 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength10,000 UNITS/ML;EQ 1MG BASE/ML
Approval Date:Dec 17, 1998TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Healthtrust
Chubb
Fuji
Cerilliant
Argus Health
US Department of Justice
QuintilesIMS
Covington
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot